Protocols and Trial Documents
Module 4 · Clinical Development

Protocols and Trial Documents

Use AI to draft, check, and harmonize clinical trial documents, from protocol sections to informed consent and plain-language summaries, while keeping medical, statistical, and ethical judgment with the people accountable for them.

A Document-Heavy Business

A single clinical trial generates a protocol, investigator’s brochure, informed consent forms in several languages, a statistical analysis plan, case report forms, monitoring plans, a clinical study report, and a plain-language results summary, plus every amendment to each. Keeping them consistent is hard, and inconsistency causes real problems: sites follow the wrong version, consent forms don’t match the procedures, and amendments pile up.

Informed consentSchedule of assessmentsInvestigator’s brochureStatistical analysis planCase report formsPlain-language summaryProtocolamendmentOne protocol amendment can ripple into every connected document.

That makes trial documents a promising area for AI, as long as you’re clear about which parts are writing and which are decisions.


Writing vs. Decisions

AI can help with the writingPeople own the decisions
Structuring a protocol against a templateChoosing endpoints and comparators
Drafting standard sections (background, procedures) from approved sourcesSetting inclusion/exclusion criteria
Checking consistency across protocol, consent, and schedule of assessmentsSample size and statistical methods
Simplifying consent language to a target reading levelBenefit–risk judgments and safety monitoring rules
Drafting plain-language summaries from approved resultsInterpreting results and their clinical meaning
Comparing amendment versions and listing changesDeciding whether a change needs ethics review

ICH E6(R3), the updated Good Clinical Practice guideline finalized in 2025, emphasizes quality by design and proportionate, risk-based approaches. That fits this split: put human expertise where errors would hurt participants or data reliability, and use tools to reduce routine burden elsewhere.

The trend toward structured protocols, such as the ICH M11 harmonized protocol template, also helps. When content follows a standard structure, AI checks and reuse across documents become more reliable.


High-Value Uses

Consistency checking

One of the safest and most useful tasks. Give an approved tool the protocol and the consent form and ask it to list every procedure, visit, or risk in one that’s missing or different in the other. You verify each finding. AI is good at producing a candidate list; you decide what’s actually inconsistent.

Amendment impact

“List every section of the protocol, consent form, and schedule of assessments affected by changing the dosing interval from every 2 weeks to every 3 weeks.” This turns a manual hunt into a checklist. You still verify it’s complete.

Readability

Consent forms are often written well above the reading level of the people signing them. AI can rewrite to a target level and flag jargon. Check that simplification didn’t change meaning: soft language about risks (“you may feel a little unwell”) can understate what participants need to know.

⚠️ Common Pitfall: Simplifying Away the Risk

Common mistake: accepting a readable AI rewrite of a consent form’s risk section without comparing it line by line with the original.

Simplification often merges, softens, or drops risks, especially rare but serious ones. Every risk in the approved source must still be present, with its frequency and seriousness intact. The ethics committee approved specific content, not a summary of it.


A Review Path for AI-Assisted Trial Documents

  1. 1 Approved sources

    Only validated inputs

  2. 2 AI draft

    Approved tool, logged

  3. 3 Author review

    Line-by-line vs. source

  4. 4 Functional review

    Medical, stats, regulatory

  5. 5 QC

    Per document SOP

  6. 6 Approval

    Named accountable owner

Meaning changed or content missing → return to author, not to the AI

Notes on this path:

  • Approved sources only. Draft from the current approved protocol, investigator’s brochure, and data, not from AI’s general knowledge of the disease or drug class.
  • Follow your SOP on disclosure. Some sponsors record AI assistance in document history; others don’t yet. Know your organization’s rule.
  • Sponsor responsibility doesn’t move. Under GCP the sponsor remains responsible for trial quality, including work done with tools and by vendors.
🧪 Try It: Run a Consistency Check on a Public Protocol

Find a published protocol and its consent form or schedule of assessments (many are posted with journal articles or on trial registries). Using an approved tool:

  1. Ask it to list every procedure and visit in the protocol’s schedule of assessments and compare it against the procedures described elsewhere in the document.
  2. Verify each discrepancy it reports.
  3. Look for one it missed. There usually is one.

What share of its findings were real? Did it miss anything important?

🧠 Knowledge Check

1. Which task is the best fit for AI assistance in trial documents?

2. An AI rewrite of a consent form's risk section reads well but describes a serious, rare risk as "possible discomfort." What should happen?

3. Under GCP, if a sponsor uses AI tools or vendors for trial documents, who is responsible for quality?

Up Next

The next lesson covers AI in trial operations and pharmacovigilance, where speed matters and errors reach patients quickly.